Bahl & Gaynor’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.78M | Sell |
34,655
-735
| -2% | -$183K | 0.04% | 152 |
|
|
2025
Q4 | $8.52M | Sell |
35,390
-175
| -0.5% | -$44.8K | 0.04% | 147 |
|
|
2025
Q3 | $9.74M | Hold |
35,565
| – | – | 0.05% | 143 |
|
|
2025
Q2 | $9.18M | Sell |
35,565
-2,334
| -6% | -$557K | 0.05% | 146 |
|
|
2025
Q1 | $8.48M | Sell |
37,899
-680
| -2% | -$159K | 0.04% | 147 |
|
|
2024
Q4 | $8.82M | Sell |
38,579
-1,594
| -4% | -$384K | 0.05% | 144 |
|
|
2024
Q3 | $9.81M | Sell |
40,173
-1,680
| -4% | -$375K | 0.05% | 141 |
|
|
2024
Q2 | $8.01M | Sell |
41,853
-171
| -0.4% | -$34.7K | 0.04% | 148 |
|
|
2024
Q1 | $8.32M | Sell |
42,024
-651
| -2% | -$119K | 0.05% | 142 |
|
|
2023
Q4 | $7.34M | Sell |
42,675
-582
| -1% | -$89.4K | 0.04% | 141 |
|
|
2023
Q3 | $6.4M | Sell |
43,257
-1,330
| -3% | -$240K | 0.04% | 142 |
|
|
2023
Q2 | $9.74M | Sell |
44,587
-1,988
| -4% | -$443K | 0.06% | 123 |
|
|
2023
Q1 | $10.2M | Sell |
46,575
-672
| -1% | -$146K | 0.05% | 121 |
|
|
2022
Q4 | $9.83M | Sell |
47,247
-835
| -2% | -$183K | 0.06% | 121 |
|
|
2022
Q3 | $10.5M | Sell |
48,082
-926
| -2% | -$211K | 0.07% | 109 |
|
|
2022
Q2 | $10.3M | Sell |
49,008
-546
| -1% | -$116K | 0.07% | 115 |
|
|
2022
Q1 | $12M | Sell |
49,554
-92
| -0.2% | -$22.3K | 0.09% | 101 |
|
|
2021
Q4 | $12.9M | Sell |
49,646
-1,392
| -3% | -$361K | 0.07% | 108 |
|
|
2021
Q3 | $13.5M | Sell |
51,038
-5,681
| -10% | -$1.55M | 0.08% | 100 |
|
|
2021
Q2 | $14M | Sell |
56,719
-399
| -0.7% | -$83.9K | 0.09% | 97 |
|
|
2021
Q1 | $11.1M | Sell |
57,118
-3,371
| -6% | -$676K | 0.07% | 105 |
|
|
2020
Q4 | $12.9M | Sell |
60,489
-715
| -1% | -$143K | 0.08% | 97 |
|
|
2020
Q3 | $10.5M | Sell |
61,204
-1,995
| -3% | -$368K | 0.07% | 100 |
|
|
2020
Q2 | $12.1M | Buy |
63,199
+320
| +0.5% | +$52.4K | 0.09% | 93 |
|
|
2020
Q1 | $9.26M | Buy |
62,879
+1,387
| +2% | +$221K | 0.08% | 101 |
|
|
2019
Q4 | $9.53M | Sell |
61,492
-2,076
| -3% | -$299K | 0.07% | 110 |
|
|
2019
Q3 | $8.59M | Sell |
63,568
-595
| -0.9% | -$78K | 0.06% | 112 |
|
|
2019
Q2 | $7.83M | Sell |
64,163
-14,627
| -19% | -$1.62M | 0.06% | 113 |
|
|
2019
Q1 | $8.19M | Buy |
78,790
+4,903
| +7% | +$506K | 0.08% | 97 |
|
|
2018
Q4 | $8.41M | Sell |
73,887
-10,869
| -13% | -$1.16M | 0.09% | 91 |
|
|
2018
Q3 | $9.78M | Sell |
84,756
-6,295
| -7% | -$690K | 0.13% | 89 |
|
|
2018
Q2 | $9.43M | Sell |
91,051
-3,451
| -4% | -$349K | 0.1% | 91 |
|
|
2018
Q1 | $9.3M | Sell |
94,502
-98,278
| -51% | -$9.29M | 0.1% | 93 |
|
|
2017
Q4 | $16.3M | Sell |
192,780
-1,473
| -0.8% | -$122K | 0.17% | 80 |
|
|
2017
Q3 | $14.9M | Buy |
194,253
+2,605
| +1% | +$199K | 0.16% | 79 |
|
|
2017
Q2 | $14.9M | Buy |
191,648
+590
| +0.3% | +$42.2K | 0.17% | 82 |
|
|
2017
Q1 | $13.8M | Buy |
191,058
+4,200
| +2% | +$290K | 0.16% | 91 |
|
|
2016
Q4 | $11.6M | Buy |
186,858
+14,205
| +8% | +$870K | 0.14% | 90 |
|
|
2016
Q3 | $11.2M | Sell |
172,653
-338
| -0.2% | -$22.5K | 0.14% | 89 |
|
|
2016
Q2 | $10.9M | Buy |
172,991
+7,878
| +5% | +$464K | 0.14% | 89 |
|
|
2016
Q1 | $9.55M | Sell |
165,113
-1,905
| -1% | -$108K | 0.13% | 92 |
|
|
2015
Q4 | $8.97M | Sell |
167,018
-1,180
| -0.7% | -$66.5K | 0.12% | 101 |
|
|
2015
Q3 | $8.57M | Buy |
168,198
+46,452
| +38% | +$2.5M | 0.12% | 101 |
|
|
2015
Q2 | $6.86M | Buy |
121,746
+606
| +0.5% | +$38.2K | 0.09% | 106 |
|
|
2015
Q1 | $8.7M | Sell |
121,140
-3,473
| -3% | -$226K | 0.12% | 102 |
|
|
2014
Q4 | $6.99M | Buy |
124,613
+350
| +0.3% | +$18.3K | 0.1% | 108 |
|
|
2014
Q3 | $6.12M | Buy |
124,263
+4,220
| +4% | +$215K | 0.09% | 108 |
|
|
2014
Q2 | $6.08M | Sell |
120,043
-16,605
| -12% | -$823K | 0.09% | 106 |
|
|
2014
Q1 | $6.11M | Buy |
136,648
+89,938
| +193% | +$4.04M | 0.1% | 105 |
|
|
2013
Q4 | $2.2M | Buy |
46,710
+32,755
| +235% | +$1.66M | 0.04% | 164 |
|
|
2013
Q3 | $737K | Buy |
+13,955
| New | +$677K | 0.01% | 213 |
|
Other funds holding RMD
VCM
VPM
DAM
Bahl & Gaynor's RMD Position: Q1 2026 in Review
Bahl & Gaynor reduced its ResMed (RMD) stake by 2.1% in Q1 2026, selling an estimated $183K and leaving 34,655 shares worth $7.78M. The position accounts for 0.04% of the portfolio, ranked #152.
Bahl & Gaynor first reported a position in RMD in Q3 2013 and has held it in 51 quarters since. The position peaked at $16.3M in Q4 2017. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Bahl & Gaynor held 34,655 shares of ResMed worth $7.78M as of Q1 2026.
- Bahl & Gaynor sold 735 ResMed shares in Q1 2026, an estimated $183K.
- ResMed made up 0.04% of Bahl & Gaynor's portfolio in Q1 2026, its #152 holding.
- Bahl & Gaynor first reported a position in ResMed in Q3 2013 and has held it in 51 quarters since.
- Bahl & Gaynor's ResMed position peaked at $16.3M in Q4 2017.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.